FDA approves Boston Scientific’s Heart Device
The U.S. Food and Drug Administration (FDA) has given approval to Boston Scientific Corp.’s heart device, which tends to reduce the risk of stroke in patients with quivering hearts.
Boston Scientific pays $600 million to J&J to settle lawsuit over Guidant Deal
On Tuesday, the global medical device-maker Boston Scientific Corp announced that it settled a $7 billion lawsuit with Johnson & Johnson for the relative bargain price of $600 million.